General


PUBLISHED: 2017 CATEGORY: TYPE: External Link Recommandations sur l’utilisation du vaccin antirotavirus chez les nourrissons

Recommandations sur l’utilisation du vaccin antirotavirus chez les nourrissons

Fournit de l’information sur l’infection à rotavirus clinique et les vaccins antirotavirus au Canada.

The present statement provides information concerning the clinical rotavirus disease and rotavirus vaccines in Canada.
The present statement provides information concerning the clinical rotavirus disease and rotavirus vaccines in Canada.
The present statement provides information concerning the clinical rotavirus disease and rotavirus vaccines in Canada.
Publisher: Société canadienne de pédiatrie

PUBLISHED: 2017 CATEGORY: Health care providers TYPE: External Link Recommendations for the use of rotavirus vaccines in infants

Recommendations for the use of rotavirus vaccines in infants

Provides information concerning the clinical rotavirus disease and rotavirus vaccines in Canada.

The present statement provides information concerning the clinical rotavirus disease and rotavirus vaccines in Canada.
The present statement provides information concerning the clinical rotavirus disease and rotavirus vaccines in Canada.
The present statement provides information concerning the clinical rotavirus disease and rotavirus vaccines in Canada.
Publisher: Canadian Paediatric Society

PUBLISHED: 2017 CATEGORY: Health care providers TYPE: External Link Update on invasive meningococcal vaccination for Canadian children and youth (CPS Position Statement)

Update on invasive meningococcal vaccination for Canadian children and youth (CPS Position Statement)

Invasive meningococcal disease (IMD) is serious, often resulting in fulminant sepsis or meningitis. IMD in Canada is primarily attributable to serogroups B and C. There are routine programs for serogroup C vaccine at 12 months of age, with some jurisdictions routinely providing additional earlier doses. Adolescents routinely receive a booster dose of serogroup C vaccine or of a quadrivalent (serogroups A, C, W and Y) vaccine. Serogroup B vaccines are not recommended for routine use pending further data on the efficacy and duration of protection from the available vaccine. However, children at increased risk for IMD should start immunization for serogroups B and C as soon as possible, assuming that they are at least two months of age. 

Meningococcal infection is serious, often resulting in fulminant sepsis or meningitis. There are two main types of meningococcal conjugate vaccine currently available in Canada: serotype C meningococcal conjugate, and quadrivalent conjugate for serotypes A, C, Y, and W-135. The immunological characteristics that inform ongoing immunization policies, as well as some of the limits of current knowledge, are presented.
Meningococcal infection is serious, often resulting in fulminant sepsis or meningitis. There are two main types of meningococcal conjugate vaccine currently available in Canada: serotype C meningococcal conjugate, and quadrivalent conjugate for serotypes A, C, Y, and W-135. The immunological characteristics that inform ongoing immunization policies, as well as some of the limits of current knowledge, are presented.
Meningococcal infection is serious, often resulting in fulminant sepsis or meningitis. There are two main types of meningococcal conjugate vaccine currently available in Canada: serotype C meningococcal conjugate, and quadrivalent conjugate for serotypes A, C, Y, and W-135. The immunological characteristics that inform ongoing immunization policies, as well as some of the limits of current knowledge, are presented.
Authors: Robinson J
Corporate Authors: Infectious Diseases and Immunization Committee
Publisher: Canadian Paediatric Society

PUBLISHED: 2017 CATEGORY: Les fournisseurs de soins, Parents, Adultes TYPE: External Link Vaccination

Vaccination

Par leurs études et leurs avis, l’Institut national de santé publique et le Comité sur l’immunisation du Québec participent au maintien de la qualité du programme québécois d’immunisation. Voici réunies dans une même page, les plus récentes publications concernant la vaccination par thématiques et quelques ressources pertinentes.

Corporate Authors: Institut national de santé publique du Québec
Publisher: Institut national de santé publique du Québec

PUBLISHED: 2017 CATEGORY: Parents, Adults TYPE: External Link Vaccine Education Center (CHOP)

Vaccine Education Center (CHOP)

Provides resources that explain how vaccines work, how they are made, who recommends vaccines, when they should be given, if they are still necessary, and, most importantly, if they are safe.

Corporate Authors: Children's Hospital of Philadelphia
Publisher: Children's Hospital of Philadelphia

PUBLISHED: 2017 CATEGORY: Health care providers, Adults TYPE: External Link Vaccine information for the public and health professionals : information about vaccine-preventable diseases (US IAC)

Vaccine information for the public and health professionals : information about vaccine-preventable diseases (US IAC)

Provides information about diseases and the vaccines that prevents them. Includes a Q & A section, photos and/or video footage, true stories of individuals who have suffered or died from the disease, descriptions of public policies, and references to other resources.

Corporate Authors: Immunization Action Coalition
Publisher: Immunization Action Coalition

PUBLISHED: 2016 CATEGORY: Parents, Health care providers, Adults TYPE: External Link 'Nosodes' are no substitute for vaccines (CPS Position Statement)

'Nosodes' are no substitute for vaccines (CPS Position Statement)

A growing antivaccine movement in Canada and elsewhere is hearing more about an unproven homeopathic therapy, ‘nosodes’, as an alternative to routine vaccines. The present statement defines nosodes and describes limitations for their use in children. There is scant evidence in the medical literature for either the efficacy or safety of nosodes, which have not been well studied for the prevention of any infectious disease in humans. Recommendations to change the labelling on these products to reflect such limitations are made.

Authors: Rieder M, Robinson J
Corporate Authors: Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee, Infectious Diseases and Immunization Committee
Publisher: Canadian Paediatric Society

PUBLISHED: 2016 CATEGORY: Health care providers, Parents, Adults, New Canadians, Travellers TYPE: External Link Flu (influenza)

Flu (influenza)

The Government of Canada provides information on influenza and vaccination against influenza.

Corporate Authors: Public Health Agency of Canada
Publisher: Public Health Agency of Canada

PUBLISHED: 2016 CATEGORY: TYPE: External Link Grippe (influenza)

Grippe (influenza)

Renseignements du Gouvernement du Canada sur l’influenza (la grippe) et la vaccination antigrippale.

Corporate Authors: Agence de la santé publique du Canada
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2016 CATEGORY: TYPE: External Link Hépatite A

Hépatite A

Renseignements du Gouvernement du Canada au sujet de l’hépatite A et le vaccin contre l’hépatite A.

Corporate Authors: Gouvernement du Canada
Publisher: Gouvernement du Canada